Medicare Weighs Cutting Breakthrough Device Payment Pathway
Medicare is considering ending its breakthrough device payment pathway, which currently fast-tracks reimbursement for FDA-designated novel medical devices. Removal would push manufacturers into standard, slower coverage reviews, undermining the commercial case for early-stage medtech innovation. No timeline for a final